Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor

Growth Factors
Timothy E AdamsColin W Ward

Abstract

The type 1 insulin-like growth factor receptor (IGF-1R) plays an essential role in mammalian growth and development, and has emerged as a candidate therapeutic target in the treatment of cancer. While the pleiotropic cellular responses elicited following tyrosine phosphorylation of the IGF-1R is usually seen to involve the direct recruitment/activation of classical intracellular effector proteins, it is now clear that cross-talk between the IGF-1R and members of distinct receptor families also plays a significant role in effecting intracellular signalling. In recent years, a number of studies have highlighted the interaction(s) between the IGF-1R and the epidermal growth factor receptor (EGFR), another transmembrane tyrosine kinase that is an established cancer target. This review describes the components of the IGF signalling system and gives an overview of the emerging picture of the interrelationship that is now known to exist between the IGF and EGF receptors.

Citations

Mar 22, 2005·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Minoru OmiCaroline N Dealy
Dec 20, 2005·The Journal of Membrane Biology·F LangS M Huber
Jun 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shailaja Kalyankrishna, Jennifer R Grandis
Jul 21, 2007·Reproduction : the Official Journal of the Society for the Study of Fertility·Thanh T NguyenPeter G Noakes
Oct 7, 2008·Human Reproduction·I Ben-AmiA Amsterdam
Jan 1, 2006·Expert Review of Endocrinology & Metabolism·Helen E JonesRobert I Nicholson
May 26, 2010·International Journal of Cancer. Journal International Du Cancer·Fusanori YotsumotoShingo Miyamoto
Feb 22, 2007·Liver International : Official Journal of the International Association for the Study of the Liver·Carmen BerasainMatías A Avila
Oct 12, 2010·BMC Cancer·Fabrice SircoulombMax Chaffanet
Oct 5, 2013·Journal of the National Cancer Institute·Dong Hoon ShinHo-Young Lee
May 5, 2007·Journal of Cancer Research and Clinical Oncology·Thomas ShpitzerRafael M Nagler
Apr 13, 2007·Expert Review of Anticancer Therapy·Richard Adams, Tim Maughan
Sep 20, 2006·The Biochemical Journal·Mehrnaz KeyhanfarBriony E Forbes
Feb 7, 2013·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Nurcan TuncbagErnest Fraenkel
Jan 1, 2011·Cancers·Carmen BerasainMatías A Avila
Mar 15, 2014·International Journal of Oncology·Albert MagroGary Rankin
Jan 9, 2019·Journal of Molecular Endocrinology·Ayse Basak EnginIpek Isik Gonul
Mar 31, 2011·Expert Opinion on Investigational Drugs·Elizabeth Buck, Mark Mulvihill
Jul 29, 2011·Annals of the New York Academy of Sciences·Tricia MooreJohn DiGiovanni
Jun 24, 2011·MAbs·Stephen J DemarestJianying Dong
Jan 11, 2013·Cancer Research·Salahaldin A TahirTimothy C Thompson
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Junichi MatsubaraTadakazu Shimoda
Dec 7, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marni Stott-MillerStephen M Schwartz
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christopher J BarnesRakesh Kumar
Jun 21, 2005·The International Journal of Biochemistry & Cell Biology·P Christian Schulze, Ulrike Späte

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.